Rod Breau

Urologic Oncologist in Ottawa, Canada

[Kari Tikkinen @KariTikkinen]

🔥 POISE-3 Urology published in European Urology 🚨

In the largest randomized placebo-controlled #urology analysis of #TranexamicAcid (TXA), #TXA reduced major #bleeding risk by 37% (from 9.5% to 6.1%) with no clear increase in #thrombosis

More at https://t.co/Yypy7vb9Jz

#EBM

[Philipp Dahm @EBMUrology]

Tremendous thanks to @Uroweb for putting on session on EBM in urology moderated by @MariaJRibal @KariTikkinen and includes @GuyattGH who coined the term EBM #EAU26

[Mike Thompson, MD, PhD, FASCO @mtmdphd]

A hospital policy of tranexamic acid to reduce (RBC) transfusion in major non-cardiac surgery: The TRACTION trial [Dec 9, 2025] Houston et al. #ASH25 LBA-5 https://t.co/nESdY4D5jP #NCT04803747 #anemia #hemeonc no increase in #VTE

[Ryan Zarychanski @RZarychanski]

@BrettLHouston presenting the results of the TRACTION trial as a late-breaking at #ASH25. In 8300 pts undergoing major non cardiac surgery, a policy of tranexamic acid reduces RBC transfusion w/ no difference in VTE at 90 days
@umanitoba @CancerCareMB @CIHR_IRSC @Research_MB

[Rod Breau @RodBreau]

A pleasure to finally share our findings of a large RCT of radical cystectomy patients from 10 Canadian institutions. To our shock, TXA did not reduce transfusion. Thank you to the patients, collaborators, and the many research staff. @WesKassouf @mcisaac_d @CIHR_IRSC

[JAMA Surgery @JAMASurgery]

In a multicenter randomized trial, tranexamic acid did not reduce blood transfusion during radical cystectomy. https://t.co/YXxsry6Shb

[JAMA Surgery @JAMASurgery]

In a multicenter randomized trial, tranexamic acid did not reduce blood transfusion during radical cystectomy. https://t.co/YXxsry6Shb

[Rod Breau @RodBreau]

@tompowles1 @DrDabestani @kalasri3 @Uromigos Thanks Tom, you can also view this study as showing PET reduced burden on patients (I.e major surgery) without worsening survival. @kalasri3 #ESMO23

[Rod Breau @RodBreau]

@WesKassouf @AmerUrological @SFreedlandMD @CanUrolAssoc @RSanchez_Salas @ChapinMD @UroOncMD Learning a lot from this trial for sure - congrats to authors and patients! Caveat is that these are high risk patients and no observation until mets arm. In lower risk PSA-recurrent, observation with delayed doublet or triplet Tx (if/when Mets detected) may still be “better”.

[BJU International @BJUIjournal]

Just published: Estimated glomerular filtration rate from the renal hypothermia trial: clinical implications by @LemireFrancis1 @RodBreau et al.

https://t.co/XgNGoytlvF

[Canadian Urological Association @CanUrolAssoc]

#CUAOnDemand
Network Meta-Analyses (NMA) in Practice
Missed the live webinar? No worries, we have you covered 😀 you can access this session and also complete the quiz for your section 3 credits.
Click here: https://t.co/wIP3lB1RLP
#UROpediaCanada
@RodBreau @WallisCJD

[Canadian Urological Association @CanUrolAssoc]

On June 23, at the CUA Mtg. in Montreal, Dr. Armen Aprikian announced the re-naming of the CUASF - KCRNC Kidney Cancer Cancer Research Grant as The Anil Kapoor Kidney Cancer Research Grant in memory of his leadership & support of kidney cancer research.
#CUA23 @KidneyCancer_Ca

[Canadian Kidney Cancer information system (CKCis) @ckcis_ca]

Hot off the press!

Check out the latest CKCF Consensus Statement; "Adjuvant therapy for RCC: 2023."

https://t.co/5dJGGCbrPg

@lalaniMD @lukelavallee @nbasappaCCI @RodBreau @BBhindi @SiTanguay @NeilReaumeMD @DrJeffreyGraham @Dominick_Bosse @ShaanDudani @DrDanielHeng

[Canadian Urological Association @CanUrolAssoc]

🥾⛺️JOIN US TONIGHT for #1! Clinical Evidence Bootcamp Series!
➡️SIGN up for 1, 2 or all 3! simply select your date & time: https://t.co/rOK2jTpqEh
@winsoncheung @WallisCJD @RodBreau @Astellas

[Canadian Kidney Cancer information system (CKCis) @ckcis_ca]

Thank you to Ameeta and the team for looking at a prediction model to determine if a renal tumour is benign or malignant using #ckcisdata!

#ckcis #AUA2023 #canadiandata #kidneycancer

@RodBreau @SiTanguay @BBhindi @UroOncMD

[ashley cox @ashleycox1000]

Outstanding presentation by Dr. Landan MacDonald ⁦predicting salvage cystectomy post TMT ⁦@DalUrology⁩ #AUA2023

[Rod Breau @RodBreau]

Dr Levitt presenting patient survey data used to inform our post prostatectomy Adj ADT trial. Partnering with patients for an acceptable design (1 yr ADT) with outcomes (avoiding radiation and recurrence) imp to patients @AUA2023 @CIHR_IRSC @ProstateCancerC @RSanchez_Salas

[Mohammad Hajiha @Drhajiha]

RIP Anil Kapoor ⁦@anilkapoormd⁩ giant in the field who contributed so much remembered #AUA2023 ⁦@CanUrolAssoc⁩

[Philipp Dahm @EBMUrology]

@VickersBiostats on Major trials in GU oncology that famously did not accrue; appeal to keep it real/simple in terms of inclusion criteria, consents…@RodBreau @ChapinMD @ChuckScalesMD @VikramNarayan #AUA2023

[Canadian Kidney Cancer information system (CKCis) @ckcis_ca]

Great job @Raees__Cassim on discussing the Canadian experience for the outcomes of cT2 RCC via partial Nx!

@RahulBansal_13 @RodBreau @nbasappaCCI @UroOncMD @SiTanguay @BBhindi

#AUA2023 #Canadiandata #registry #kidneycancer #CKCis

[Rod Breau @RodBreau]

High quality guidelines are so important. This is a great way to learn more about how to create and use clinical practice guidelines +/- new pair of cowboy boots

[Philipp Dahm @EBMUrology]

Calling all urologists; great opportunity for everyone interested in developing trustworthy guidelines. Space limited. @Cochrane_US @C_Incontinence @CochraneUrology @DrSteveCanfield @m_e_nielsen @ChuckScalesMD @RodBreau @drimranomar @JenAngerMD @GiuliaILane @VikramNarayan